Katarina Luptakova

Katarina Luptakova is a declared insider of Xilio Therapeutics, Inc., with filings sourced from SEC (Form 4). Between 1 January 2025 and 1 January 2026, the trades on record add up to 2 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

On 5 January 2026 came the latest disclosure, an option exercise in Xilio Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.